Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
ATZUMI (DIHYDROERGOTAMINE MESYLATE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
ATZUMI
NDA
Get alerts
DIHYDROERGOTAMINE MESYLATE | N217901 | SATSUMA PHARMACEUTICALS INC
1 strength
7 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
7 unique patents, 1 exclusivity by expiration date
Active (7)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
Today
10758532
Dec. 11, 2039
10792253
Aug. 4, 2037
11744967
Oct. 12, 2041
11872314
Aug. 4, 2037
12102754
Oct. 12, 2041
12263162
Dec. 11, 2039
12594273
Sep. 24, 2033
NP
Apr. 30, 2028
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 5.2MG BASE
RLD
7 patents
1 exclusivity
▴
POWDER;NASAL | Approved: Apr 30, 2025
Patents (7)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
10758532
Dec 11, 2039
—
—
Yes
—
—
10792253
Aug 4, 2037
—
—
Yes
—
—
11744967
Oct 12, 2041
—
—
Yes
—
—
11872314
Aug 4, 2037
—
—
Yes
—
—
12102754
Oct 12, 2041
—
—
Yes
—
—
12263162
Dec 11, 2039
—
—
Yes
—
—
12594273
Sep 24, 2033
—
—
Yes
—
—
Exclusivities (1)
Code
Date
Status
NP
Apr 30, 2028
Active